STOCK TITAN

Io Biotech, Inc. (IOBTQ) Net Income by Year

IOBTQ

Io Biotech, Inc. reported a net loss of $95.5M in fiscal year 2024. This represents a decrease of 10.9% from the prior fiscal year. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Io Biotech, Inc. has filed alongside them.

FY2024 annual
Net Income -$95.5M
YoY -10.9%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IOBTQ Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$95.5M-10.9%-$86.1M-20.5%-$71.5M-5.3%-$67.9M-463.7%-$12.0M

IOBTQ Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Net Income-$8.4M+65.1%-$26.2M-26.7%-$22.4M-15.2%N/A-$24.0M-10.8%-$20.7M+2.3%-$19.5M-14.2%N/A-$21.7M-38.2%-$21.2M-14.5%-$17.0M+0.9%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Io Biotech, Inc. financials

Frequently Asked Questions

What was Io Biotech, Inc.'s net income in fiscal year 2024?

Io Biotech, Inc. reported a net loss of $95.5M in fiscal year 2024.

How fast is Io Biotech, Inc.'s net income growing?

Io Biotech, Inc. (IOBTQ) net income fell by 10.9% year over year, from -$86.1M to -$95.5M in fiscal year 2024.

How has Io Biotech, Inc.'s net income changed over the years?

Across the 5 fiscal years this page covers, Io Biotech, Inc. (IOBTQ) net income went from -$12.0M in fiscal year 2020 to -$95.5M in fiscal year 2024.

Io Biotech, Inc. (IOBTQ) reported -$8.4M in net income in Q3 2025. This represents an increase of 65.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Io Biotech, Inc. (IOBTQ) reported on that line in every period on record.